News
Valneva shares tumble after suspension of US chikungunya vaccine licence
Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the licence for its chikungunya vaccine, Ixchiq, with immediate effect, citing serious safety concerns.
Valneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.
Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly 22% lower ahead of the morning bell at $9.09.
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker ...
The cities of Foshan and Guangzhou, in southern China, have been battling the virus for two months. Nearly 10,000 cases have ...
Health agencies recommend wearing insect repellent and loose-fitting clothing to prevent bites from mosquitoes carrying the ...
8don MSN
What is chikungunya virus? Symptoms and advice as cases rise among travellers returning to UK
What is chikungunya virus? Symptoms and advice as cases rise among travellers returning to UK - UK health authorities have ...
DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...
Dear J.: Chikungunya may not sound like a real medical condition, but it is a viral disease that was first found in West ...
There have been 33 locally-transmitted cases of the tropical disease in a neighborhood in the city of Vitrolles in the south ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback